These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8324485)

  • 1. [The clinical pharmacology and efficacy of Essentiale in liver diseases].
    Skakun NP
    Eksp Klin Farmakol; 1993; 56(1):69-72. PubMed ID: 8324485
    [No Abstract]   [Full Text] [Related]  

  • 2. ["Essential" phospholipids in hepatology (experimental and clinical tests)].
    Kuntz E; Gundermann KJ; Schneider E
    Ter Arkh; 1994; 66(2):66-72. PubMed ID: 8160152
    [No Abstract]   [Full Text] [Related]  

  • 3. [Natural antioxidants as hepatoprotectors].
    Buniatian ND; Gerasimova OA; Sakharova TS; Iakovleva LV
    Eksp Klin Farmakol; 1999; 62(2):64-7. PubMed ID: 10340135
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of essentiale in chronic liver diseases in patients with pulmonary tuberculosis].
    Blikhar EM; Skakun NP
    Probl Tuberk; 1988; (3):41-4. PubMed ID: 3387393
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of hepatoprotectors containing phospholipids on rats with experimental acute pancreatitis].
    Saratikov AS; Vengerovskiĭ AI; Mozzhelin ME; Sukhodolo IV
    Eksp Klin Farmakol; 2004; 67(4):35-7. PubMed ID: 15500043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of trofopar, AICA phosphate and Essentiale on the detoxifying function and blood circulation of the liver in lesions in man].
    Nikolaeva AP; Loginov AS; Bendikov EA
    Farmakol Toksikol; 1991; 54(3):56-9. PubMed ID: 1915826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical pharmacology of hepatoprotectors].
    Chekman IS
    Lik Sprava; 2001; (1):15-9. PubMed ID: 15311683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
    Kidd P; Head K
    Altern Med Rev; 2005 Sep; 10(3):193-203. PubMed ID: 16164374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phosphogliv: mechanism of therapeutic action and clinical efficacy].
    Archakov AI; Sel'tsovskiĭ AP; Lisov VI; Tsyganov DI; Kniazhev VA; Ipatova OM; Torkhovskaia TI
    Vopr Med Khim; 2002; 48(2):139-53. PubMed ID: 12189622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Essential phospholipids in the treatment of chronic pyelonephritis].
    Ovchinnikov AA; Tsvettsikh VE; Berdichevskiĭ BA; Lykov VN; Suktanbaev VR; Murychev AV
    Urol Nefrol (Mosk); 1996; (4):7-9. PubMed ID: 8928353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Essential phospholipids in combined therapy of chronic circulatory insufficiency].
    Golochevskaia VS; Baranskaia EK; Trofimenko IV; Balakhonova NP; Burmakin IA; Kop'ev VI; Zadorozhnaia OO
    Klin Med (Mosk); 1997; 75(5):30-3. PubMed ID: 9235405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of the preparation Essenciale in chronic ischemic heart disease].
    Kukes VG; Senik EA; Gneushev ET; Potekaeva SA; Milovanova NM
    Kardiologiia; 1978 Jun; 18(6):79-82. PubMed ID: 353358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Essential" phospholipids in liver diseases].
    Maiwald L
    Fortschr Med; 1986 Apr; 104(14):299-302. PubMed ID: 3710395
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of essential phospholipids in regulation of functional systems].
    Afanas'ev VV; Luk'ianova IIu; Klimantsev SA
    Eksp Klin Gastroenterol; 2007; (5):124-35. PubMed ID: 18389609
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute ischemic hypoxia of the liver].
    Duca S
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1982; 31(3):223-31. PubMed ID: 6217501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of phosphatidylcholine liposomes for correction of phospholipid composition of mitochondria from medulla oblongata and frontal lobe during hemorrhagic shock in cats].
    Leskova GF; Udovichenko VI
    Biull Eksp Biol Med; 1997 Apr; 123(4):374-7. PubMed ID: 9190172
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is there an effective therapy for liver diseases? A multicentric clinical study].
    Stoll B; Scholz U; Haase W
    Med Welt; 1976 Apr; 27(15):707-12. PubMed ID: 772360
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dose-dependent effect of buprenorphine on the phospholipid composition of the liver cell membrane in cats during hemorrhagic shock].
    Leskova GF; Udovichenko VI
    Biull Eksp Biol Med; 1994 Aug; 118(8):164-5. PubMed ID: 7949039
    [No Abstract]   [Full Text] [Related]  

  • 19. ["Essentiale" in the treatment of liver diseases].
    Blaser E
    Schweiz Arch Tierheilkd; 1968 Nov; 110(11):582-7. PubMed ID: 5753485
    [No Abstract]   [Full Text] [Related]  

  • 20. [Polyunsaturated phosphatidyl choline in combination with vitamin B complex in the treatment of liver diseases in drug addicts].
    Giammona G; Marano P; Patti F
    Clin Ter; 1986 Dec; 119(5):373-7. PubMed ID: 2951054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.